26,131 Shares in Cardinal Health, Inc. $CAH Bought by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 26,131 shares of the company’s stock, valued at approximately $5,370,000.

Several other large investors have also added to or reduced their stakes in the business. Aventura Private Wealth LLC acquired a new stake in Cardinal Health in the fourth quarter valued at $25,000. Jones Financial Companies Lllp lifted its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in Cardinal Health in the third quarter valued at $31,000. Turning Point Benefit Group Inc. acquired a new stake in Cardinal Health in the third quarter valued at $31,000. Finally, Cape Investment Advisory Inc. lifted its stake in Cardinal Health by 61.1% in the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock valued at $33,000 after acquiring an additional 80 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $196.57 on Friday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60. The firm has a market cap of $46.04 billion, a price-to-earnings ratio of 30.06, a P/E/G ratio of 1.19 and a beta of 0.53. The firm’s 50-day simple moving average is $203.52 and its 200 day simple moving average is $208.79.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period last year, the firm earned $2.35 earnings per share. Cardinal Health’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.19%.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Wells Fargo & Company cut their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Evercore cut their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. William Blair assumed coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. cut their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Finally, Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.